A study looks at the efficacy of MYLO: a monthly disposable silicone hydrogel contact lens designed with BHVI‘s patented EDOF technology to slow the progression of myopia.

EDOF technology has previously been studied in terms of visual performance and efficacy in slowing myopic progression. Also, some data on short-term visual effects of MYLO have recently been published.

Now a prospective longitudinal study aims to assess the efficacy in managing the growth of myopia in children of MYLO after one year of use. To measure the objective, the researchers analysed: visual acuities (VA), subjective refraction, axial length and cycloplegic autorefraction at first visit and after 12 months. There was an experimental group of children wearing MYLO and a control group wearing glasses. As for the results, we have extracted the main ones:

  • Firstly, “all participants completed the study after 1 year.” This is important because it means that children were happy with both methods of correction and wore them successfully.
  • Secondly, “at one year follow-up, there was a statistically significant difference in the evolution of myopia between the experimental group and the control group (0.34 versus 0.57D respectively, p<0.001).” This could be translated as an efficacy of 40% on average in terms of spherical equivalent.
Spherical Equivalent Shift from baseline to 1-year
  • Finally, “there was less axial elongation in the contact lens group compared to the control (0.19mm vs. 0.34mm respectively, p<0.001).” This could be interpreted as an efficacy of 44% on average with reference to axial length.
Axial Length Shift from baseline to 1-year

You can check the abstract below:


Efficacy of an EDOF Soft Contact Lens in Managing Myopia Progression

Authors: SERGIO DÍAZ GÓMEZ1, Portugalete; AMAIA URKIA SOLORZANO1, Bilbao; MERCEDES BURGOS MARTÍNEZ3, Madrid; JESÚS CARBALLO ÁLVAREZ2, Madrid.

1 – Integral Ophthalmological Clinic (COI), Bilbao; 2 – Complutense University of Madrid; 3 – R&D Department at mark’ennovy.
Keywords: myopia, extended depth, axial length.

PURPOSE

To assess the efficacy in managing the growth of myopia in children of the new Mylo® contact lens (mark’ennovy, Spain) based on extended depth of focus (EDOF) design at one year follow-up.

METHODS

Prospective longitudinal study carried out at the Integral Ophthalmological Clinic in Bilbao, Spain. Ninety children were assessed with ages between 6 and 13, myopia between -0.75 and -10.00D and cylinder ≤0.75D. Forty-five children were assigned to the experimental group fitted with EDOF contact lenses and 45 went to the control group who wore glasses. Measurements of VA, subjective refraction, axial length (IOL Master 700 Biometer, Zeiss, Germany) and cycloplegic autorefraction (OPD Scan III, Nidek, Japan) were taken at first visit and after 12 months. For the analysis of the data, the SPSS 28 software (SPSS Inc, USA) was used. The normality of the variables was checked with the Kolmogorov-Smirnov test. Student’s t-test was used for normal samples and Wilcoxon test for the rest. The significance level was set at 0.05.

RESULTS

All participants completed the study after 1 year. At the beginning of the study, the experimental group (20 males, 25 females) was 10.9±1.6 years old and had a spherical equivalent of -2.80±1.81D while the control group (19 males, 26 females) was 11.2±1.1 years old and had a spherical equivalent -2.69±0.99D. At one year follow-up, there was a statistically significant difference in the evolution of myopia between the experimental group and the control group (0.34 versus 0.57D respectively, p<0.001). In addition, there was less axial elongation in the contact lens group compared to the control (0.19mm vs. 0.34mm respectively, p<0.001). Comparing both groups, the efficacy was 40% for the spherical equivalent and 44% in terms of axial length.

CONCLUSIONS

The use of EDOF contact lenses in myopic children reduced the progression of the refractive value and axial elongation when compared to the group using glasses.

Abstract included in the Scientific Program of OPTOM2022 (27th Congress of Optometry, Contact Lenses and Ophthalmic Optics), from April 1 to 3, 2022, with ISBN: 978-84-123998-2-0
Translated from the Spanish original by Irene Lozano Sierra.

You can download the Spanish abstract here.


At mark’ennovy, we are committed to science and innovation in every way, always with a mindset of continuous improvement. Therefore, we support various organizations and universities with their studies related to contact lenses.

The mark’ennovy team would also like to thank Sergio, Amaia and Jesús for their hard work.

23

Maggio 2022

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Mark’ennovy

mark'ennovy è un produttore di lenti a contatto morbide mensili personalizzate . Noi crediamo che dovresti essere messo in condizioni di applicare la giusta lente a tutte le prescrizioni, ecco perché partiamo dalle misurazioni uniche di ogni singolo occhio e quindi produciamo individualmente la lente più adatta da applicare . La nostra impareggiabile combinazione di parametri, geometrie, materiali ed esperta consulenza tecnica è supportata da una tecnologia di produzione di «prima classe» a livello mondiale e siamo focalizzati esclusivamente sul professionista della visione.